Ifp Advisors, Inc Aldeyra Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,404 shares of ALDX stock, worth $7,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,404Holding current value
$7,272% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ALDX
# of Institutions
146Shares Held
39.2MCall Options Held
620KPut Options Held
435K-
Perceptive Advisors LLC New York, NY9.28MShares$48 Million2.23% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$28.4 Million21.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$19.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.8 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$9.07 Million2.26% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $302M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...